A Breast Cancer Drug That Gets In The Brain? Cascadian Sees A Way Forward
Shutterstock Breast cancer patients sometimes end up dying when their tumors spread all the way to the brain. Some very good drugs already exist for patients with breast cancer, especially ones with tumors that overexpress the HER2 marker, but that success has raised a new question: Can drugmakers take another step, [...]
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Luke Timmerman, Contributor Tags: NASDAQ:CASC NASDAQ:PBYI Source Type: news